Lecanemab Maintenance Dosing in Early Alzheimer’s Disease: Support for Continued Dosing from Clinical, Pharmacology, and Modeling Data (S23.007)
To present support from the latest clinical, pharmacology, and modeling data for continued long-term maintenance lecanemab dosing further clinical benefit.
Authors
- Arnaud Charil (ORCID: https://orcid.org/0000-0002-3437-1710)
- Shobha Dhadda (ORCID: https://orcid.org/0000-0002-7290-7168)
- Steven M. Hersch (ORCID: https://orcid.org/0000-0001-5948-6672)
- Larisa Reyderman
- Pratik Bhagunde
- Michael C. Irizarry (ORCID: https://orcid.org/0000-0002-0246-2511)
- Lynn D. Kramer
- Natasha Penner (ORCID: https://orcid.org/0009-0003-4904-9526)
Institutions
- Eisai (Japan) (JP)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211170
- Citations
- 2
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 3.01